Understanding of the pathophysiology of obstructive sleep apnoea, a common
yet relatively newly recognised condition, has advanced rapidly in recent y
ears. This condition produces major acute haemodynamic changes and causal r
elationships with arterial hypertension and cardiovascular morbidity have b
een proposed. The role that the autonomic nervous system plays in mediating
these cardiovascular changes has been the focus of intensive research acti
vity and the development of new techniques in physiological monitoring, suc
h as spectral analysis of heart rate variability, Finapres blood pressure m
onitoring, measurement of muscle sympathetic nerve activity, radionuclide t
ests and animal models of obstructive sleep apnoea have substantially incre
ased the knowledge base. The acute haemodynamic changes are associated with
high levels of sympathetic discharge and with fluctuating parasympathetic
activity. There are also chronic changes in baroreceptor and chemoreceptor
reflexes associated with an increase in baseline daytime sympathetic activi
ty and abnormal vagal reflex responses to voluntary respiratory manoeuvres.
These acute autonomic changes appear to be provoked by a combination of st
imuli triggered by hypoxaemia, upper airway responses, ventilatory changes
and arousal. The mechanisms of the chronic autonomic changes are less clear
; it is likely that recurrent hypoxaemia is important, but the roles of rec
urrent ventilatory stress and arousal are not cleat: Normalising respiratio
n with CPAP therapy prevents the acute cardiovascular changes and reduces t
he acute sympathetic over-activity, and in compliant patients, restores abn
ormal vagal responses to normal and reduces excess chronic sympathetic acti
vity. Whether or not this produces a reduction in long term cardiovascular
morbidity Is not established.